Tehran: The first study of the safety and effectiveness of locally developed coronavirus vaccines in Iran has begun on Tuesday.
The vaccine, produced by Shifa Pharmed, part of a state-owned pharmaceutical conglomerate, is the first in the country to reach human trials.
President Hassan Rouhani has said that Iran is partnering with another country to produce another vaccine that can be tested on human participants in February. He did not give more information about this.
Iran has been worst hit by the Covid-19 epidemic in West Asia where more than 1.2 million people have been infected so far and about 55,000 people have died from the virus infection.
In the first phase clinical trial, a total of 56 participants will be given two doses of the Iran-made vaccine within two weeks. Hamid Hussaini informed that the results will be announced about one month after the second dose.